Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hyperthermia × Gemcitabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 579 Carcinoma, Non-Small-Cell Lung 274 Breast Neoplasms 138 Neoplasms 135 Urinary Bladder Neoplasms 132 Lung Neoplasms 132 Neoplasm Metastasis 115 Cholangiocarcinoma 95 Ovarian Neoplasms 82 Biliary Tract Neoplasms 78 Nasopharyngeal Carcinoma 64 Lymphoma, Large B-Cell, Diffuse 63 Lymphoma 56 Recurrence 54 Sarcoma 53 Gallbladder Neoplasms 53 Carcinoma, Transitional Cell 44 Hodgkin Disease 42 Colorectal Neoplasms 41 Lymphoma, Non-Hodgkin 40 Triple Negative Breast Neoplasms 38 Adenocarcinoma 38 Fallopian Tube Neoplasms 37 Bile Duct Neoplasms 36 Non-Muscle Invasive Bladder Neoplasms 27 Carcinoma 27 Uterine Cervical Neoplasms 26 Carcinoma, Ovarian Epithelial 26 Unspecified Adult Solid Tumor, Protocol Specific 24 Urethral Neoplasms 22

Interventions

Diathermy 16 Radiotherapy 9 Drug Therapy 4 Cisplatin 4 Melphalan 3 Immune Checkpoint Inhibitors 3 Fluorouracil 3 Cytoreduction Surgical Procedures 3 tislelizumab 2 Surgical Procedures, Operative 2 Radiation 2 Immunotherapy 2 Conization 2 Brachytherapy 2 spartalizumab 1 sodium thiosulfate 1 anlotinib 1 Therapeutics 1 Solutions 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Mitomycin 1 Leucovorin 1 Laser Therapy 1 Laparotomy 1 Ifosfamide 1 Hyperthermic Intraperitoneal Chemotherapy 1 Hyperthermia, Induced 1 Hydrogen Peroxide 1 Gemcitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01077427 2017-11-17

HEAT

Klinikum der Universitaet Muenchen, Grosshadern

Phase 3 Unknown

Gastrointestinal

Hyperthermia, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡